2/26/2010

Ultima will study treatment of pulmonary embolismusing the Ekos Ekosonic Endovascualr device. (read more...)

2/16/2010

ISTO Technologies, an AHV Portfolio Company, to Present at the Canaccord Adams Musculoskeletal Conference http://www.marketwire.com/press-release/ISTO-Technologies-Inc-to-Present-at-the-Canaccord-Adams-Musculoskeletal-Conference-1117373.htm (read more...)

10/15/2009

Augmenix announced today that it has closed a $6.1 million Series B financing. The round was led by Ascension Health Ventures (AHV) in St. Louis, Mo., with continued participation by existing investors, Versant Ventures and Pinnacle Ventures. Also participating were Catalyst Health Ventures and several private investors. (read more...)

6/5/2008

Haven Behavioral Healthcare (“Haven”) a leading provider of specialty behavioral health services, announced that Ascension Health Ventures (“AHV”) has made an equity investment in the Company, joining existing investors Thoma Cressey Bravo, Clayton Associates and Haven management as shareholders. AHV is the general partner of CHV II, L.P., an investment fund formed by Ascension Health, Catholic Health Initiatives, Catholic Health East and Catholic Healthcare West. (read more...)

8/27/2008

BioImagene, the leading provider of innovative digital pathology solutions for preclinical research and cancer diagnosis, today announced the closing of a $26 million series D financing round led by Burrill & Company. Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support. (read more...)

1/2/2008

Ascension Health announced today that Catholic Healthcare West (CHW) has become a limited partner in CHV II, LP, by acquiring a portion of Ascension Health’s commitment to this $200 million venture capital fund focused on making venture investments in the healthcare industry. (read more...)